Diabetes tied to increased risk for endometrial cancer

  • Saed L & al.
  • BMC Cancer
  • 31 May 2019

  • curated by Sarfaroj Khan
  • UK Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • This meta-analysis suggests that women with diabetes are at increased risk for endometrial cancer compared to those without diabetes.

Why this matters

  • Multiple studies have shown a positive association between diabetes and the incidence of endometrial cancer with several biological mechanisms.
  • Findings may be useful in developing endometrial cancer prevention plans for women with diabetes.

Study design

  • 22 studies (13, case-control; 9, cohort) met eligibility criteria after a search across electronic databases.
  • Funding: Systematic Review Network Center, Iran University of Medical Sciences.

Key results

  • Pooled result of 14 studies showed that diabetes was associated with an increased risk for endometrial cancer (relative risk [RR], 1.72; 95% CI, 1.48-2.01; I2, 66.7%).
  • The risk for endometrial cancer was higher in women with diabetes in cohort (RR, 1.56; 95% CI, 1.21-2.01; I2, 69.0%) and case-control studies (RR, 1.85; 95% CI, 1.53-2.23; I2, 60.7%).
  • Pooled results of hospital-based studies vs other studies showed a higher risk for endometrial cancer in women with diabetes (RR, 4.10; 95% CI, 2.09-8.01).
  • 3 of the primary studies adjusted for body mass index showed that diabetes was associated with higher risk for endometrial cancer (RR, 2.45; 95% CI, 1.14-5.26).
  • Similarly, 4 of the primary studies adjusted for weight demonstrated a higher risk for endometrial cancer in women with diabetes (RR, 1.89; 95% CI, 1.22-2.94).

Limitations

  • Heterogeneity among studies.
  • Study did not mention the duration of diabetes and type of treatment.